Editing Khat (section)

===Effects by timeframe===
'''Immediate'''
*alertness<ref name=AlZarouni />{{rp|6}}
*arousal<ref name=AlZarouni />{{rp|5}}
*concentration<ref name=AlZarouni />{{rp|7}}<ref name="Kalix" />
*confidence<ref name=AlZarouni />{{rp|6}}
*constipation<ref name=AlZarouni />{{rp|9}}
*dilated pupils
*[[euphoria]]<ref name="Kciy" />
*friendliness<ref name=AlZarouni />{{rp|7}}
*increased blood pressure<ref name="Kciy" /><ref name=AlZarouni />{{rp|6}}
*increased heart rate<ref name="Kciy" /><ref name=AlZarouni />{{rp|5}}
*insomnia<ref name=AlZarouni />{{rp|7}}
*[[mania]]
*[[psychosis]]<ref name="AlZarouni" />{{rp|8}}
*suppressed appetite<ref name=AlZarouni />{{rp|8}}
*talkativeness<ref name=AlZarouni />{{rp|8}}
*[[thought disorder]]<ref name=AlZarouni />{{rp|9}}
*verbosity<ref name=AlZarouni />{{rp|8}}

'''Long-term'''
*[[Depression (clinical)|depression]]<ref name=AlZarouni />{{rp|10}}
*infrequent hallucinations<ref name="Kciy" /><ref name=AlZarouni />{{rp|10}}
*impaired inhibition (similar to [[alcohol (drug)|alcohol]])<ref name=AlZarouni />{{rp|10}}<ref>{{Cite journal|title=Long-term effects of chronic khat use: impaired inhibitory control |journal=Frontiers in Psychology |volume=1 |pages=219 |publisher=Frontiers in cognition |date=12 January 2011 |doi=10.3389/fpsyg.2010.00219 |pmid=21833274 |pmc=3153824 |last1=Hommel |first1=Bernhard |last2=Bajo |first2=Maria Teresa |last3=Van Den Wildenberg |first3=Wery P. M. |last4=Ruiz |first4=Manuel J. |last5=Colzato |first5=Lorenza S. |doi-access=free }}</ref>
*increased risk of [[myocardial infarction]] (heart attack)<ref name=AlZarouni />{{rp|10}}<ref>{{cite journal|last1=Al-Motarreb |first1=A. L. |last2=Broadley |first2=K. J. |title=Coronary and aortic vasoconstriction by cathinone, the active constituent of khat |journal=Autonomic & Autacoid Pharmacology |volume=23 |issue=5–6 |pages=319–26 |date=October–December 2003 |doi=10.1111/j.1474-8673.2004.00303.x|pmid=15255816 }}</ref>
*oral cancer<ref>{{cite web|url=https://adf.org.au/drug-facts/khat/|title=Khat – DrugInfo|date=20 September 2006|publisher=Alcohol and Drug Foundation|access-date=28 July 2010}}</ref><ref>{{cite web |last1=Hassan |first1=Nageeb |last2=Gunaid |first2=Abdullah |last3=Murray-Lyon |first3=Iain |url=http://www.al-bab.com/bys/articles/hassan05.htm |title=British-Yemeni Society: The impact of khat-chewing on health: a re-evaluation |publisher=Al-bab.com |access-date=28 July 2010 |url-status=dead |archive-url=https://web.archive.org/web/20100607133117/http://www.al-bab.com/bys/articles/hassan05.htm |archive-date=7 June 2010 |df=dmy-all }}</ref>
*[[psychosis]] in extreme cases in the genetically predisposed<ref name="Kciy" /><ref name=AlZarouni />{{rp|11}}
*[[weight loss]]

'''Indeterminate'''
*[[death]]<ref name=AlZarouni />{{rp|12}}<ref name="Khat Chewing: A smokeless gun">{{cite journal|last1=Mateen |first1=F. J. |last2=Cascino |first2=G. D. |title=Khat Chewing: A smokeless gun? |journal=Mayo Clinic Proceedings |volume=85 |pages=971–73 |pmid=21037041 |doi=10.4065/mcp.2010.0658 |issue=11 |pmc=2966359 |date=November 2010}}</ref>
*stroke following [[acute coronary syndrome]] (clogging of the artery)<ref group="note">either from impaired insight into symptoms by the khat chewer, delay to care, or poorly understood [[pathophysiological]] mechanisms</ref><ref name=AlZarouni />{{rp|12}}<ref name="Khat Chewing: A smokeless gun"/>